AI has quickly evolved from a niche technology to a transformative force in healthcare. What began with automating simple ...

This new form of exercise – called blood flow-restricted resistance training – could offer fresh hope for people with RA, researchers report in the journal Disability and Rehabilitation.

Scientists at St. Jude Children’s Research Hospital found that patients with sickle cell disease who received gene therapy experienced a return to normal blood flow in the brain.

Beyond Summary: The Road to a Proactive Intelligence Ambience's vision is to make Patient Recap the clinician's first stop for any patient, in any care setting.

An industry first: Ambience Healthcare becomes the only ambient AI to deliver comprehensive patient context before encounters, extending beyond documentation to clinical workflow transformation ...

Chart Industries Inc. (NYSE:GTLS) is one of the 10 most undervalued industrial stocks to buy according to analysts. On June 4, UBS analyst Manav Gupta maintained a Buy rating on Chart Industries ...

Chart Industries Inc. (NYSE:GTLS) is one of the 10 most undervalued industrial stocks to buy according to analysts.

SAN FRANCISCO — Both dyspnea and respiratory drive went down with vs. without nasal high-flow therapy in orally intubated patients, according to research presented at the American Thoracic ...

Flowserve Corporation and Chart Industries, Inc. merge for $300M synergies, sparking investor skepticism on growth and strategy. Click for my take on FLS and GTLS.

Chart Industries and Flowserve agreed to combine in an all-stock merger valued at ~$19B including debt, creating a differentiated leader in industrial process technologies.

(Reuters) -U.S.-based equipment manufacturer Chart Industries and flow control systems maker Flowserve Corp agreed to merge in an all-stock deal, valuing the combined company at about $19 billion.